(Q55476190)

12 July 2018

title

Posterior fossa boost in medulloblastoma: an analysis of dose to surrounding structures using 3-dimensional (conformal) radiotherapy. (English)

1 reference

12 July 2018

0 references

0 references

Paulino AC

1

1 reference

12 July 2018

Narayana A

series ordinal

2

1 reference

12 July 2018

Mohideen MN

series ordinal

3

1 reference

12 July 2018

Jeswani S

series ordinal

4

1 reference

12 July 2018

language of work or name

English

0 references

publication date

1 January 2000

1 reference

12 July 2018

International Journal of Radiation Oncology Biology Physics

published in

1 reference

12 July 2018

volume

46

1 reference

12 July 2018

issue

2

1 reference

12 July 2018

page(s)

281-286

1 reference

12 July 2018

The use of 3D conformal radiotherapy (3D CRT) to spare the cochlea in patients with medulloblastoma.

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0360-3016%2899%2900367-3

7 January 2021

Posterior fossa: analysis of a popular technique for estimating the location in children with medulloblastoma.

1 reference

https://api.crossref.org/works/10.1016%2FS0360-3016%2899%2900367-3

7 January 2021

Defining the superior border of posterior fossa radiation treatment fields

1 reference

https://api.crossref.org/works/10.1016%2FS0360-3016%2899%2900367-3

7 January 2021

Quality control of radiotherapeutic treatment of medulloblastoma in a multicentric study: the contribution of radiotherapy technique to tumour relapse. The French Medulloblastoma Group.

1 reference

https://api.crossref.org/works/10.1016%2FS0360-3016%2899%2900367-3

7 January 2021

Pediatric medulloblastoma: radiation treatment technique and patterns of failure.

1 reference

https://api.crossref.org/works/10.1016%2FS0360-3016%2899%2900367-3

7 January 2021

Spontaneous seeding of medulloblastoma: results of cerebrospinal fluid cytology and arachnoid biopsy from the cisterna magna.

1 reference

https://api.crossref.org/works/10.1016%2FS0360-3016%2899%2900367-3

7 January 2021

Patterns of failure following treatment for medulloblastoma: is it necessary to treat the entire posterior fossa?

1 reference

https://api.crossref.org/works/10.1016%2FS0360-3016%2899%2900367-3

7 January 2021

Neuropsychologic functioning of survivors of childhood medulloblastoma randomized to receive conventional or reduced-dose craniospinal irradiation: a Pediatric Oncology Group study.

1 reference

https://api.crossref.org/works/10.1016%2FS0360-3016%2899%2900367-3

7 January 2021

Neuropsychological sequelae of medulloblastoma in adults

1 reference

https://api.crossref.org/works/10.1016%2FS0360-3016%2899%2900367-3

7 January 2021

Hypothalamic-pituitary dysfunction after radiation for brain tumors.

1 reference

https://api.crossref.org/works/10.1016%2FS0360-3016%2899%2900367-3

7 January 2021

Growth and endocrine disorders secondary to cranial irradiation

1 reference

https://api.crossref.org/works/10.1016%2FS0360-3016%2899%2900367-3

7 January 2021

The cranial-spinal junction in medulloblastoma: does it matter?

1 reference

https://api.crossref.org/works/10.1016%2FS0360-3016%2899%2900367-3

7 January 2021

Thyroid dysfunction as a late effect in survivors of pediatric medulloblastoma/primitive neuroectodermal tumors: a comparison of hyperfractionated versus conventional radiotherapy.

1 reference

https://api.crossref.org/works/10.1016%2FS0360-3016%2899%2900367-3

7 January 2021

Cancer of the thyroid in children: a report of 28 cases

1 reference

https://api.crossref.org/works/10.1016%2FS0360-3016%2899%2900367-3

7 January 2021

Dentofacial development in long-term survivors of acute lymphoblastic leukemia. A comparison of three treatment modalities.

1 reference

https://api.crossref.org/works/10.1016%2FS0360-3016%2899%2900367-3

7 January 2021

Late effects of radiation therapy in the head and neck region

1 reference

https://api.crossref.org/works/10.1016%2FS0360-3016%2899%2900367-3

7 January 2021

10.1016/S0360-3016(99)00367-3

Identifiers

DOI

1 reference

12 July 2018

PubMed ID

10661333

1 reference

12 July 2018